;

7/20/2021

  • Grünenthal provides 200,000 Euros in emergency aid for the City of Stolberg, which is significantly affected by the floods.
  • In addition, Grünenthal will donate 200,000 euros to the coalition "Germany Helps" (Aktion Deutschland Hilft).

 

Aachen, Germany, 20 July 2021 – Grünenthal is deeply saddened by the situation of the people affected by the flood disaster in Germany. Staff and executive management have set up a relief programme to provide immediate support for people who urgently need help.

Grünenthal donated 200,000 euros as immediate support for the severely affected town of Stolberg. The company will donate an additional 200,000 euros to the coalition "Germany Helps" (Aktion Deutschland Hilft) to support nationwide measures.

"Our thoughts and solidarity are with the people in our neighbourhood in the greater Aachen region and the other affected areas," says Gabriel Baertschi, CEO Grünenthal. "We will provide unbureaucratic support to the helpers on the ground."

Grünenthal supports employees who are personally affected by the flood disaster with financial and material means and paid leave.

About Grünenthal
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are available in around 100 countries. In 2020, Grünenthal employed around 4,500 people and achieved sales of € 1.3 bn.

 

More information: www.grunenthal.com

Follow us on:

 

Fabia Kehren

Head External Communications and Editorial Management

Grünenthal GmbH


52099 Aachen

E-Mail Fabia.Kehren@grunenthal.com

Phone +49 241 569-3269